These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 29956594)
21. Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program. Rodriguez BL; Curb JD; Burchfiel CM; Huang B; Sharp DS; Lu GY; Fujimoto W; Yano K Diabetes Care; 1996 Jun; 19(6):587-90. PubMed ID: 8725856 [TBL] [Abstract][Full Text] [Related]
22. Impaired Glucose Tolerance or Newly Diagnosed Diabetes Mellitus Diagnosed during Admission Adversely Affects Prognosis after Myocardial Infarction: An Observational Study. George A; Bhatia RT; Buchanan GL; Whiteside A; Moisey RS; Beer SF; Chattopadhyay S; Sathyapalan T; John J PLoS One; 2015; 10(11):e0142045. PubMed ID: 26571120 [TBL] [Abstract][Full Text] [Related]
23. Hypertriglyceridaemia predicts subsequent long-term risk of cardiovascular events in Chinese adults: 23-year follow-up of the Daqing Diabetes Study. Wang J; Shen X; He S; An Y; Gong Q; Li H; Zhang B; Shuai Y; Chen Y; Hu Y; Li G Diabetes Metab Res Rev; 2019 Sep; 35(6):e3163. PubMed ID: 30939629 [TBL] [Abstract][Full Text] [Related]
24. Impact of diabetes and prediabetes on the short-term prognosis in patients with acute ischemic stroke. Tanaka R; Ueno Y; Miyamoto N; Yamashiro K; Tanaka Y; Shimura H; Hattori N; Urabe T J Neurol Sci; 2013 Sep; 332(1-2):45-50. PubMed ID: 23810779 [TBL] [Abstract][Full Text] [Related]
25. Higher blood pressure predicts diabetes and enhances long-term risk of cardiovascular disease events in individuals with impaired glucose tolerance: Twenty-three-year follow-up of the Daqing diabetes prevention study. Li X; Wang J; Shen X; An Y; Gong Q; Li H; Zhang B; Shuai Y; Chen Y; Hu Y; Li G J Diabetes; 2019 Jul; 11(7):593-598. PubMed ID: 30556339 [TBL] [Abstract][Full Text] [Related]
26. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial. Holman RR; Coleman RL; Chan JCN; Chiasson JL; Feng H; Ge J; Gerstein HC; Gray R; Huo Y; Lang Z; McMurray JJ; Rydén L; Schröder S; Sun Y; Theodorakis MJ; Tendera M; Tucker L; Tuomilehto J; Wei Y; Yang W; Wang D; Hu D; Pan C; Lancet Diabetes Endocrinol; 2017 Nov; 5(11):877-886. PubMed ID: 28917545 [TBL] [Abstract][Full Text] [Related]
27. Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes. Chou P; Li CL; Wu GS; Tsai ST Diabetes Care; 1998 Jul; 21(7):1183-7. PubMed ID: 9653617 [TBL] [Abstract][Full Text] [Related]
28. [Prevalence of type II diabetes mellitus in population of Krakow]. Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585 [TBL] [Abstract][Full Text] [Related]
29. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China. Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321 [TBL] [Abstract][Full Text] [Related]
30. Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study. Doi Y; Ninomiya T; Hata J; Fukuhara M; Yonemoto K; Iwase M; Iida M; Kiyohara Y Stroke; 2010 Feb; 41(2):203-9. PubMed ID: 19940278 [TBL] [Abstract][Full Text] [Related]
31. The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men. Wei M; Gibbons LW; Mitchell TL; Kampert JB; Lee CD; Blair SN Ann Intern Med; 1999 Jan; 130(2):89-96. PubMed ID: 10068380 [TBL] [Abstract][Full Text] [Related]
32. Diabetes mellitus, impaired glucose tolerance, and hyperinsulinemia in an elderly population. The Rotterdam Study. Stolk RP; Pols HA; Lamberts SW; de Jong PT; Hofman A; Grobbee DE Am J Epidemiol; 1997 Jan; 145(1):24-32. PubMed ID: 8982019 [TBL] [Abstract][Full Text] [Related]
33. Impaired glucose tolerance is a risk factor for stroke in a Japanese sample--the Funagata study. Oizumi T; Daimon M; Jimbu Y; Wada K; Kameda W; Susa S; Yamaguchi H; Ohnuma H; Tominaga M; Kato T Metabolism; 2008 Mar; 57(3):333-8. PubMed ID: 18249204 [TBL] [Abstract][Full Text] [Related]
34. Impaired glucose tolerance predicts all-cause mortality among older men at high risk for cardiovascular disease in China. Fang F; Wang N; Yan S; Wang L; Lu Y; Li J; Li H; Pham G; Li C; Leng SX; Tian H Prim Care Diabetes; 2019 Dec; 13(6):495-504. PubMed ID: 30862424 [TBL] [Abstract][Full Text] [Related]
35. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864 [TBL] [Abstract][Full Text] [Related]
36. [Predictors of abnormal glucose tolerance in persons at risk of type 2 diabetes: the RIAD study]. Henkel E; Köhler C; Temelkova-Kurktschiev T; Hanefeld M Dtsch Med Wochenschr; 2002 May; 127(18):953-7. PubMed ID: 11987015 [TBL] [Abstract][Full Text] [Related]
37. Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. Brown DW; Giles WH; Greenlund KJ; Valdez R; Croft JB J Cardiovasc Risk; 2001 Aug; 8(4):227-33. PubMed ID: 11551001 [TBL] [Abstract][Full Text] [Related]
38. Increased arterial stiffness in subjects with impaired glucose tolerance and newly diagnosed diabetes but not isolated impaired fasting glucose. Li CH; Wu JS; Yang YC; Shih CC; Lu FH; Chang CJ J Clin Endocrinol Metab; 2012 Apr; 97(4):E658-62. PubMed ID: 22337914 [TBL] [Abstract][Full Text] [Related]
39. Changes in glucose metabolism in people with different glucose metabolism disorders at baseline: follow-up results of a Finnish national diabetes prevention programme. Rautio N; Jokelainen J; Oksa H; Saaristo T; Peltonen M; Puolijoki H; Tuomilehto J; Vanhala M; Moilanen L; Uusitupa M; Keinänen-Kiukaanniemi S Diabet Med; 2015 Dec; 32(12):1611-6. PubMed ID: 25864699 [TBL] [Abstract][Full Text] [Related]
40. Premature death and risk of cardiovascular disease in young-onset diabetes: a 23-year follow-up of the Da Qing Diabetes Study. Hui Y; Wang J; An Y; Gong Q; Li H; Zhang B; Shuai Y; Chen Y; Hu Y; Li G Endocrine; 2019 Jul; 65(1):46-52. PubMed ID: 31001730 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]